ARPP19 mRNA was overexpressed in 58% (n = 28) of the cohort2 sample panel (Supplementary Figure S3a), thus providing an independent validation for high rate of overexpression of ARPP19 in a subset of adult AML patients. The gene discussed is ARPP19; the disease is acute myeloid leukemia.